ARTICLE AD BOX

- Deutsche Telekom strengthens Injective’s security and decentralization by joining as a validator.
- Institutional backing from Deutsche Telekom enhances Injective’s blockchain growth and DeFi integration.
In a significant advancement for decentralized finance (DeFi), Deutsche Telekom, one of Europe’s largest telecommunications companies, has expanded its blockchain involvement by becoming a validator for the Injective network. This move follows its previous collaboration with Meta Pool to pioneer decentralized AI on NEAR Protocol, as reported by CNF.
The partnership highlights the increasing institutional interest in blockchain technology and aims to enhance the security and decentralization of Injective’s Layer-1 blockchain, which is optimized for financial applications. The update was also shared in a tweet by Injective on its official X account.
Today, Deutsche Telekom MMS joins Injective's validator set.
This collaboration bridges traditional enterprise with blockchain tech, reinforcing Injective as the leading institutional-friendly Layer 1 network.
Here is why this is a big deal pic.twitter.com/YKvi2S8QMZ
— Injective (@injective) February 27, 2025
Deutsche Telekom Joins Injective’s Validator Set
Deutsche Telekom’s subsidiary, Deutsche Telekom MMS, has officially joined Injective’s validator set. As a validator, Deutsche Telekom MMS will play a crucial role in validating transactions, proposing new blocks, ensuring cross-chain interoperability, and participating in on-chain governance by voting on network proposals.
This initiative aligns with Deutsche Telekom’s broader strategy to leverage its infrastructure to support and secure blockchain networks, fostering true decentralization.
Oliver Nyderle, Head of Web3 Infrastructure at Deutsche Telekom MMS, emphasized the company’s commitment to combining technology with security and trust, ensuring a more secure network for all users.
Injective’s Growing Role in Real-World Asset Tokenization
Injective has been making significant strides in the blockchain space, particularly in integrating real-world assets (RWAs) into the DeFi ecosystem. The Nirvana Chain upgrade, implemented on February 18, 2025, introduced advanced RWA oracle support, facilitating the seamless tokenization and integration of various assets on-chain.
This upgrade enhances data accuracy for tokenized assets, making Injective a more reliable platform for financial applications.
Deutsche Telekom’s Ongoing Blockchain Engagement
Beyond Injective, Deutsche Telekom has an established presence in blockchain, notably serving as a validator for Chainlink, a decentralized oracle network. This ongoing partnership enhances the security and reliability of Chainlink’s data feeds, which are essential for various smart contract applications.
A CNF report highlighted that Deutsche Telekom began staking Chainlink (LINK) on Flow Networks, further reinforcing its blockchain engagement.
Chainlink Price and Market Impact
At the time of writing, Chainlink (LINK) is trading at approximately $13.98, reflecting a 10.20% decrease over the past 24 hours. The token has experienced an intraday high of $15.77 and a low of $13.48.
The continued collaboration between Deutsche Telekom and Chainlink underscores the growing synergy between traditional enterprises and blockchain platforms, driving innovation and trust within the decentralized ecosystem.